In addition, in the 3D spheroid model, the EGFR-targeted ICED-N increased tumor accumulation with 513-fold greater targeting efficacy to MG-63 (EGFR+) cells than the control fibroblast (EGFR−) cells (Figure 7B). Here, EGFR is linked to neoplasm.